IGXBio
Lenexa, Kansas, United States
About IGXBio
IGXBio, Inc. is a biotechnology company developing advanced DNA immunotherapies for HIV infection.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $470.0K
- Funding stage: Seed
- Last round: Seed (Dec 2010)
- Website: igxbio.com
- Phone: (888)744-9246
Industries & Categories
Biotechnology, Health Care, Information Technology
Canonical: https://fsome.com/organization/igxbio-2569396 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.